ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Tsuguo Naruke
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nomori, H.
Right arrow Articles by Suemasu, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nomori, H.
Right arrow Articles by Suemasu, K.
Related Collections
Right arrow Lung - cancer

Ann Thorac Surg 2001;72:879-884
© 2001 The Society of Thoracic Surgeons


Original article: general thoracic

What is the advantage of a thoracoscopic lobectomy over a limited thoracotomy procedure for lung cancer surgery?

Hiroaki Nomori, MDa, Hirotoshi Horio, MDa, Tsuguo Naruke, MDa, Keiichi Suemasu, MDa

a Department of Thoracic Surgery, Saiseikai Central Hospital, Tokyo, Japan

Accepted for publication May 17, 2001.

Address reprint requests to Dr Nomori, Department of Thoracic Surgery, Saiseikai Central Hospital, 1-4-17 Mita, Minato-ku, Tokyo 108-0073, Japan
e-mail: hnomori{at}qk9.so-net.ne.jp


    Abstract
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Background. To clarify any advantages of video-assisted thoracoscopic surgery (VATS) over anterior limited thoracotomy (ALT) for lobectomy in lung cancer, we compared the two procedures in a retrospective analysis.

Methods. Sex- and age-matched (± 5 years) lung cancer patients in clinical stage I who underwent lobectomy by means of VATS (n = 33) or ALT (n = 33) were compared in terms of the number of resected lymph nodes, operating time, intraoperative blood loss, duration of postoperative chest tube drainage, and chest pain. Pain was evaluated using a visual analog scale and analgesic requirements. Vital capacity (VC), respiratory muscle strength, and results of a 6-minute walking (6 MW) test were also compared preoperatively and 1 and 2 weeks postoperatively.

Results. Compared with the ALT group, the VATS group experienced less pain between postoperative day (POD) 1 and POD 7 (p < 0.05 to 0.001) and had lower analgesic requirements up to POD 7 (p < 0.001). However, there were no significant differences in pain on POD 14. There were also no significant differences in intraoperative factors or in the postoperative impairment of VC, respiratory muscle strength, and 6 MW test results.

Conclusions. Although VATS lobectomy reduces chest pain during the first week after surgery compared with ALT, this advantage is lost within 2 weeks. Both techniques result in similar impairments of pulmonary function, respiratory muscle strength and walking capacity. Therefore, if curative resection of lung cancer by VATS would be technically difficult for any reason, including the surgeon’s skill and experience, a limited open thoracotomy would be preferable from the standpoints of safety and the patient’s prognosis.


    Introduction
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Although video-assisted thoracoscopic surgery (VATS) is gaining popularity as a technique for performing lobectomy in lung cancer, other minimally invasive types of thoracotomy, such as limited or muscle-sparing thoracotomies, are also widely used [15]. However, although the VATS approach is less invasive than a posterolateral thoracotomy, its advantages over a limited or muscle-sparing thoracotomy for lung cancer surgery are still a matter of controversy [4, 5].

Between January 1997 and July 1999 we conducted a study to investigate the usefulness of anterior limited thoracotomy (ALT) for lung cancer surgery; we reported that it had advantages over posterolateral thoracotomy in both reducing chest pain and diminishing the impairment of pulmonary function between 1 week and 6 months after surgery [1]. Since August 1999 we have been using VATS lobectomy with mediastinal lymph node dissection for clinical stage I lung cancer. To determine any advantages of VATS lobectomy over ALT we compared the two procedures in terms of intraoperative factors (number of resected lymph nodes, operating time, and blood loss) and postoperative recovery (duration of chest tube drainage, chest pain, length of hospital stay, impairment of pulmonary function, respiratory muscle strength, and results of a 6-minute walking [6 MW] test).


    Material and methods
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Study groups
Between August 1999 and December 2000 a total of 63 patients with primary lung cancer underwent surgical treatment at our hospital. For all 38 patients in clinical stage I we attempted VATS lobectomy and mediastinal lymph node dissection. Five of these patients were converted to an open thoracotomy procedure during surgery (because of perinodal invasion of lymph node metastasis in 3 patients, the need for a bronchoplasty in 1 patient, and bleeding in another). As a result, 33 patients successfully underwent VATS lobectomy and lymph node dissection. In the present study we investigated intraoperative factors (the number of resected lymph nodes, operating time, and blood loss during surgery) and postoperative recovery (the duration of chest tube drainage, chest pain, pulmonary function, respiratory muscle strength, and the outcome of a 6 MW test) in these 33 patients. As a control group we used the 33 most recent patients with clinical stage I lung cancer who had undergone lobectomy by means of ALT between April 1998 and July 1999 and who could be matched with the VATS lobectomy group for sex and age (± 5 years), as shown in Table 1. No significant differences were observed between the VATS and ALT groups in terms of preoperative pulmonary function, respiratory muscle strength, the distance covered during the 6 MW test (6 MWD), lobectomy site, tumor size, or pathologic tumor stage. All patients underwent general anesthesia and intubation with a double-lumen endotracheal tube to allow selective contralateral ventilation.


View this table:
[in this window]
[in a new window]
 
Table 1. Patient Characteristics

 
VATS lobectomy procedure
The VATS lobectomy was performed with the patients in the lateral decubitus position, with the arm elevated and secured on a padded armboard. A skin incision approximately 6 cm long was made, generally on the midaxillary line (Fig 1). The serratus anterior muscle was divided but the latissimus dorsi muscle did not require division. The chest was generally entered through the fourth intercostal space, which was opened to about 2 cm using a thoracic opener. Three further access ports (internal diameter, 11.5 mm) were created by making three 2 cm-long incisions: one on the midclavicular line in the fourth intercostal space, one on the midaxillary line in the seventh or eighth intercostal space, and one on the posterior axillary line in the sixth intercostal space. The operating surgeon usually divided the pulmonary vessels and bronchus under direct vision through the minithoracotomy site, while an assistant surgeon assisted through the other ports, using the TV monitor for guidance. For the mediastinal lymph node dissection, the thoracic opener was removed and the operating surgeon dissected the lymph nodes under TV monitor guidance. The resected lung was removed in a surgical bag. A chest tube was placed in the thoracic cavity through the port on the midaxillary line. During closure, the muscle was reapproximated and sutured, but the ribs were not.



View larger version (11K):
[in this window]
[in a new window]
 
Fig 1. Skin incisions for lobectomy by means of video-assisted thoracoscopic surgery. Area with oblique lines indicates opening in thorax.

 
Anterior limited thoracotomy
The ALT was performed as previously described [1]. Briefly, a skin incision approximately 12 cm long was made below the breast (Fig 2). The pectoralis major muscle was divided and the chest entry was made through the fourth intercostal space. The cartilage was usually disconnected and a thoracic opener was used to create a 8 to 10–cm square opening in the thorax, enabling the surgeon to insert one hand into the thoracic cavity.



View larger version (19K):
[in this window]
[in a new window]
 
Fig 2. Illustration of anterior limited thoracotomy. The chest is entered through the fourth intercostal space with anterior cartilage junction disconnected. Two retractors are used, one for the intercostal space and the other for the posterior site. Area with oblique lines indicates opening in the thorax. (IV = the fourth rib; V = the fifth rib.)

 
Postoperative analgesia
All patients received continuous epidural analgesia with morphine (usually 10 mg per dose) until postoperative day (POD) 3. Thereafter, an indomethacin suppository was administered on an "as required" basis during the hospitalization period.

Postoperative chest tube drainage
The chest tube was generally removed on the morning after surgery if the drainage volume was less than 400 mL per day and no air leakage was observed.

Evaluation of postoperative pain
Postoperative pain was assessed from POD 1 to 14 using the visual analog scale described by Hazelrigg and colleagues [3]. This involved patients marking a pain score from 0 mm (no pain) to 100 mm (most severe pain imaginable) on a 100-mm line drawing. The visual analog scale was explained to the patients preoperatively and was administered by the nursing staff three times a day during hospitalization. The pain experienced on each day was calculated as the mean of the three measurements. To ensure that there were no obvious psychological differences in pain perception between the groups, a pain reference was determined preoperatively for each patient by using the visual analog scale to assess the degree of pain experienced during a skin puncture to draw blood, as described by Giudicelli and colleagues [4]. Analgesic requirements from POD 1 to 7 were also examined.

Pulmonary function tests
We measured vital capacity (VC), forced vital capacity and forced expiratory volume in 1 second (FEV1) with the subjects seated, using a dry rolling-seal spirometer (Fudac-50, Fukuda Co, Tokyo, Japan). Predicted normal VC volumes were determined by sex, height and age, using the formulae of Baldwin and colleagues [6]. Pulmonary function measurements were obtained less than 2 days before surgery and repeated 1 and 2 weeks after surgery. The percentage change in the postoperative VC compared with the preoperative volume was evaluated as follows: VC (% of preoperative level) = postoperative VC / preoperative VC x 100 (%).

Measurements of respiratory muscle strength
Maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP) were measured as before [7, 8], according to the method described by Black and Hyatt [9]. Briefly, an obstructive mouthpiece (2.5 cm in diameter, 6.5 cm long) with a small air leak was used to measure mouth pressure during MIP and MEP at functional residual capacity (FRC), and these values were used as an index of inspiratory and expiratory muscle strength, respectively. The mouthpiece was connected to a pressure transducer (TP-604T, Nihon Kohden Co, Tokyo, Japan) and measurements were made with the subjects seated and wearing a nose clip. Each subject performed a series of maximal inspiratory and expiratory maneuvers, which were repeated until at least three readings were sustained for 2 to 3 s with a variation of less than 10%. The highest value was used in the analysis. The MIP and MEP measurements were obtained less than 2 days before surgery and repeated 1 and 2 weeks after surgery. The percentage changes in postoperative MIP and MEP compared with the preoperative values were evaluated as follows: MIP (% of preoperative level) = postoperative MIP / preoperative MIP x 100 (%); and MEP (% of preoperative level) = postoperative MEP / preoperative MEP x 100 (%).

Six-minute walking test
The 6 MW test was conducted by physiotherapists according to a standardized protocol [10]. Patients were instructed to walk from one end of a 90-m hallway to the other at their own pace, attempting to go as far as possible in the allotted 6 minutes. They were allowed to rest during the test, but were instructed to resume walking as soon as they were able to do so. The total distance covered during the 6 MW test was measured. Oxygen saturation (SpO2) and the pulse rate were measured during the test using a finger oxymeter (ONYX 9500, Nonin Medical Inc, Plymouth, MN), and values were assessed at the start and end of the test. The initial 6 MW test was conducted less than 2 days before the operation, with a postoperative test 1 week after operation. The percentage change in the postoperative 6 MWD compared with the preoperative value was evaluated as follows: 6 MWD (% of preoperative level) = postoperative 6 MWD / preoperative 6 MWD x 100 (%).

Discharge from hospital
Because the 6 MW and pulmonary function tests were performed on POD 7, most of the patients were discharged from the hospital on or after POD 7. The pulmonary function tests 2 weeks after surgery were generally conducted in the outpatient department.

Statistical analysis
All data are expressed as means ± standard deviation. All data were analyzed using the two-tailed Student’s t test. Between-group differences with p less than 0.05 were regarded as significant.


    Results
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Intraoperative data, postoperative chest tube drainage, and hospital stay
Data on the intraoperative factors and postoperative chest tube drainage are summarized in Table 2. There were no significant differences in either the operating time or the intraoperative blood loss between the VATS and ALT groups. The mean number of resected hilar and mediastinal lymph nodes on both sides of the lung was similar in both groups. The duration of chest tube drainage was somewhat shorter in the VATS group than in the ALT (p = 0.06) but the difference was not statistically significant. The length of hospital stay after operation was 7.3 ± 1.3 days in the VATS group and 7.9 ± 1.3 days in the ALT (difference not significant).


View this table:
[in this window]
[in a new window]
 
Table 2. Data For Operation and Postoperative Tube Drainage

 
These data of the VATS group were from 33 patients who successfully underwent VATS lobectomy, which did not include the 5 patients who underwent conversion to open thoracotomy. The data of 38 patients, including these 5, were as follows: operating time 289 ± 84 minutes, blood loss 206 ± 57 mL, duration of chest tube drainage 1.1 ± 0.5 days, and number of resected lymph nodes was 20 ± 8 in the right lung and 14 ± 3 in the left. These results also showed no significant difference compared to the ALT group.

Postoperative chest pain
Chest pain data are summarized in Table 3. Preoperative pain reference values were similar in both the VATS and ALT groups. The mean postoperative pain scores from POD 1 to POD 7 were significantly lower in the VATS group than in the ALT group (p < 0.05 to 0.001), and the mean number of occasions on which analgesics were required during this period was significantly lower in the VATS group (p < 0.001). However, on POD 14 there was no significant difference in mean pain scores between the two groups (p = 0.09).


View this table:
[in this window]
[in a new window]
 
Table 3. Mean Daily Pain Scores (Visual Analog Scale) and Analgesic Requirements

 
Postoperative pulmonary function, respiratory muscle strength, and 6-minute walking tests
Because the chest tubes were removed within 5 days of surgery in all patients, the postoperative VC, MIP, MEP, and 6 MWD values were all measured without chest tubes in situ. All patients except for one in the VATS group (who lived a considerable distance away from the hospital) completed the 2-week postoperative follow-up for pulmonary function, respiratory muscle strength, and 6 MW testing. Table 4 summarizes the data on the percentage of preoperative level in postoperative VC, MIP, MEP, and 6 MWD values. Although there were no significant differences in these changes between the VATS and ALT groups at either 1 or 2 weeks after surgery, the percentages of preoperative level in MEP and 6 MWD 1 week after surgery were somewhat higher in the VATS group than in the ALT group (p = 0.07 and 0.06, respectively). The mean decrease in SpO2 during the 6 MW test 1 week after surgery was 2.5% ± 2.7% in the VATS group and 2.4% ± 1.8% in the ALT group; again, this difference was not significant.


View this table:
[in this window]
[in a new window]
 
Table 4. Postoperative Percentage Changes in Vital Capacity, Respiratory Muscle Strength, and Distance Covered During 6-Minute Walking Test Compared With Preoperative Values

 
Mortality and morbidity
No deaths or postoperative complications, such as atelectasis, pneumonia, arrhythmia or wound infection, occurred in either group. There were also no prolonged (ie, lasting for > 5 days) air leaks in either group.


    Comment
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
In the present study, the only advantage of VATS over ALT was a decrease in chest pain during the first week after surgery; by 2 weeks, however, this advantage was no longer apparent. We found no significant differences in the operating time, intraoperative blood loss, postoperative chest tube drainage, or in impairment of postoperative pulmonary function, respiratory muscle strength, and 6 MW test results between the two groups.

With regard to chest pain, we previously reported that pain scores between 1 week and 6 months after surgery were significantly lower after ALT than after posterolateral thoracotomy [1]. In the present study we demonstrated that VATS resulted in a further lowering of the pain score for 1 week after surgery. It therefore appears that the more limited the thoracic wound, the less the postoperative pain. We could not find any difference in the length of hospital stay after surgery between the two groups. Most of the patients were discharged from the hospital after 6 MW and pulmonary function tests on POD 7.

Several investigators have demonstrated the advantages of VATS or limited thoracotomy over posterolateral thoracotomy in improving postoperative pulmonary function [11, 12]. Because thoracotomy injures the respiratory muscles of the chest wall and reduces total chest compliance regardless of whether lung resection is performed [8, 13, 14], postoperative pulmonary function, respiratory muscle strength, and 6 MWD would be expected to be influenced by alterations in thoracotomy procedures. However, in the present study we could not detect any differences in these factors between VATS and ALT. These findings are in line with those of Giudicelli and colleagues [4], who found no significant differences in postoperative pulmonary function between VATS and latissimus dorsi muscle-sparing lateral thoracotomy. In addition, we previously reported that ALT produced less impairment of postoperative pulmonary function than did posterolateral thoracotomy, but that there was no significant difference between ALT and latissimus dorsi muscle-sparing anteroaxillary thoracotomy [1]. We therefore believe that preserving the latissimus dorsi muscle is one of the most important factors in maintaining adequate pulmonary function after surgery.

Although we could not demonstrate any significant advantages of VATS over ALT in terms of the postoperative recovery of pulmonary function, respiratory muscle strength, and walking capacity, the recovery of MEP and 6 MWD was somewhat better in the VATS group than in the ALT group at 1 week after surgery and these differences almost reached significance. We consider that the improvements in the postoperative impairment of MEP and 6 MWD seen in the VATS group could be due to the significant decrease in pain associated with VATS. Because patients usually experience chest pain more severely during active expiration (such as coughing) than during active inspiration, postoperative MEP values could be more significantly affected by ALT than by VATS because of chest pain. In addition, although the 6 MWD is well known to be reduced by cardiopulmonary dysfunction [10, 15], its impairment after lung surgery could be partially due to chest pain, because patients experiencing pain would not be able to walk as far after the operation as before surgery. Therefore, the relative improvement of 6 MWD in the VATS group compared with the ALT group at 1 week after surgery could be due to the decrease in chest pain associated with the former procedure. An adequate MEP value is important in allowing coughing to expectorate sputum, which in turn lowers the risk of postoperative pulmonary complications such as atelectasis and pneumonia. Early improvements in 6 MWD could also help patient mobility in the early period after surgery, which is associated with a decreased risk of postoperative pulmonary complications. Although the between-group differences in the postoperative recoveries of both MEP and 6 MWD did not reach significance, VATS lobectomy could have a beneficial impact on the risk of postoperative pulmonary complications, especially in elderly or poor-risk patients, because of the earlier recovery of expiratory muscle strength and walking capacity after the decrease in chest pain associated with this technique.

Although VATS lobectomy decreased chest pain after surgery, the most important feature of lung cancer surgery is its ability to cure the tumor, thereby ensuring a good prognosis. Because lung cancers (except for locally advanced ones) can be completely resected by means of a limited or muscle-sparing thoracotomy, it should be kept in mind that if curative resection of a lung cancer would be difficult to perform by means of a VATS procedure for any reason, including the skill and experience of the surgeon, a limited or muscle-sparing thoracotomy would be preferable from the standpoints of safety and ensuring complete resection of the tumor. In conclusion, VATS lobectomy could be accepted as a legitimate surgical option in the treatment of early-stage lung cancer for reducing early postoperative pain.


    References
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 

  1. Nomori H., Horio H., Suemasu K. Anterior limited thoracotomy with intrathoracic illumination for lung cancer. Chest 1999;115:874-880.[Abstract/Free Full Text]
  2. Nomori H., Horio H., Fuyuno G., Kobayashi R. Non-serratus-sparing antero-axillary thoracotomy with disconnection of anterior rib cartilage. Chest 1997;111:572-576.[Abstract/Free Full Text]
  3. Hazelrigg S.R., Landreneau R.J., Boley T.M., et al. The effect of muscle-sparing versus standard posterolateral thoracotomy on pulmonary function, muscle strength, and postoperative pain. J Thorac Cardiovasc Surg 1991;101:394-401.[Abstract]
  4. Giudicelli R., Thomas P., Lonjon T., et al. Video-assisted minithoracotomy versus muscle-sparing thoracotomy for performing lobectomy. Ann Thorac Surg 1994;58:712-718.[Abstract]
  5. Kirby T.J., Mack M.J., Landreneau R.J., et al. Lobectomy-video-assisted thoracic surgery versus muscle-sparing thoracotomy: a randomized trial. J Thorac Cardiovasc Surg 1995;109:997-1002.[Abstract]
  6. Baldwin E.D., Cournand A., Richards E.W., Jr Pulmonary insufficiency: I. Physiological classification, clinical methods of analysis, standard values, in normal subjects. Medicine 1948;27:243-278.[Medline]
  7. Nomori H., Kobayashi R., Fuyuno G., Morinaga S., Yashima H. Assessment of preoperative respiratory muscle training in patients undergoing thoracic surgery with special reference to postoperative pulmonary complication. Chest 1994;105:1782-1788.[Abstract/Free Full Text]
  8. Nomori H., Horio H., Fuyuno G., Kobayashi R., Yashima H. Respiratory muscle strength after lung resection with special reference to age and procedures of thoracotomy. Eur J Cardiothorac Surg 1996;10:352-358.[Abstract]
  9. Black L.F., Hyatt R.E. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969;99:696-702.[Medline]
  10. Butland R.J.A., Pang J., Gross E.R., Woodcock A.A., Geddes D.M. Two, six and 12 minute walking tests in respiratory disease. Br Med J 1982;284:1607-1608.
  11. Kaseda S., Aoki T., Hangai N., Shimizu K. Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy. Ann Thorac Surg 2000;70:1644-1666.[Abstract/Free Full Text]
  12. Lemmer J.H., Jr, Gomez N.H., Symreng T., Ross A.F., Rossi N. Limited lateral thoracotomy. Arch Surg 1990;125:873-877.[Abstract]
  13. Bolton J.W.R., Weiman D.S. Physiology of lung resection. Clin Chest Med 1993;14:293-303.[Medline]
  14. Peters R.M., Wellons H.A., Htwe T.M., Hill C. Total compliance and work of breathing after thoracotomy. J Thorac Cardiovasc Surg 1969;57:348-355.[Medline]
  15. Guyatt G.H., Sullivan M.J., Thompson P.J., et al. The six-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-923.[Abstract]



This article has been cited by other articles:


Home page
Cancer Res.Home page
B. Fisher
Biological Research in the Evolution of Cancer Surgery: A Personal Perspective
Cancer Res., December 15, 2008; 68(24): 10007 - 10020.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. O. Jones, G. Casali, and W. S. Walker
Does failed video-assisted lobectomy for lung cancer prejudice immediate and long-term outcomes?
Ann. Thorac. Surg., July 1, 2008; 86(1): 235 - 239.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. G. Nicastri, J. P. Wisnivesky, V. R. Litle, J. Yun, C. Chin, F. R. Dembitzer, and S. J. Swanson
Thoracoscopic lobectomy: Report on safety, discharge independence, pain, and chemotherapy tolerance
J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 642 - 647.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. P. Shaw, F. R. Dembitzer, J. P. Wisnivesky, V. R. Litle, T. S. Weiser, J. Yun, C. Chin, and S. J. Swanson
Video-Assisted Thoracoscopic Lobectomy: State of the Art and Future Directions
Ann. Thorac. Surg., February 1, 2008; 85(2): S705 - S709.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. A. D'Amico
Thoracoscopic Segmentectomy: Technical Considerations and Outcomes
Ann. Thorac. Surg., February 1, 2008; 85(2): S716 - S718.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. L. Demmy and C. Nwogu
Is Video-Assisted Thoracic Surgery Lobectomy Better? Quality of Life Considerations
Ann. Thorac. Surg., February 1, 2008; 85(2): S719 - S728.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Z. Atkins, D. H. Harpole Jr, J. H. Mangum, E. M. Toloza, T. A. D'Amico, and W. R. Burfeind Jr
Pulmonary Segmentectomy by Thoracotomy or Thoracoscopy: Reduced Hospital Length of Stay With a Minimally-Invasive Approach
Ann. Thorac. Surg., October 1, 2007; 84(4): 1107 - 1113.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Varela, A. Brunelli, G. Rocco, M. F. Jimenez, M. Salati, and T. Gatani
Evidence of Lower Alteration of Expiratory Volume in Patients With Airflow Limitation in the Immediate Period After Lobectomy
Ann. Thorac. Surg., August 1, 2007; 84(2): 417 - 422.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. Nomori, K. Ikeda, T. Mori, S. Shiraishi, H. Kobayashi, K. Iwatani, K. Kawanaka, and T. Kobayashi
Sentinel node identification in clinical stage Ia non-small cell lung cancer by a combined single photon emission computed tomography/computed tomography system
J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 182 - 187.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. P. Petersen, D. Pham, W. R. Burfeind, S. I. Hanish, E. M. Toloza, D. H. Harpole Jr, and T. A. D'Amico
Thoracoscopic Lobectomy Facilitates the Delivery of Chemotherapy after Resection for Lung Cancer
Ann. Thorac. Surg., April 1, 2007; 83(4): 1245 - 1250.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Shigemura, A. Akashi, S. Funaki, T. Nakagiri, M. Inoue, N. Sawabata, H. Shiono, M. Minami, Y. Takeuchi, M. Okumura, et al.
Long-term outcomes after a variety of video-assisted thoracoscopic lobectomy approaches for clinical stage IA lung cancer: A multi-institutional study.
J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 507 - 512.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Shiraishi, T. Shirakusa, M. Hiratsuka, S. Yamamoto, and A. Iwasaki
Video-assisted thoracoscopic surgery lobectomy for c-T1N0M0 primary lung cancer: its impact on locoregional control.
Ann. Thorac. Surg., September 1, 2006; 82(3): 1021 - 1026.
[Abstract] [Full Text] [PDF]


Home page
MMCTSHome page
N. Durrleman and G. Massard
Thoracic incisions - general considerations
MMCTS, August 10, 2006; 2006(0810): 1420.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. P. Petersen, D. Pham, E. M. Toloza, W. R. Burfeind, D. H. Harpole Jr, S. I. Hanish, and T. A. D'Amico
Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer.
Ann. Thorac. Surg., July 1, 2006; 82(1): 214 - 218.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Bernard, L. Brondel, E. Arnal, and J.-P. Favre
Evaluation of respiratory muscle strength by randomized controlled trial comparing thoracoscopy, transaxillary thoracotomy, and posterolateral thoracotomy for lung biopsy.
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 596 - 600.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Shiraishi, K. Kawahara, T. Shirakusa, S. Yamamoto, and T. Maekawa
Risk Analysis in Resection of Thoracic Esophageal Cancer in the Era of Endoscopic Surgery.
Ann. Thorac. Surg., March 1, 2006; 81(3): 1083 - 1089.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. F. Munden, S. S. Swisher, C. W. Stevens, and D. J. Stewart
Imaging of the Patient with Non-Small Cell Lung Cancer
Radiology, December 1, 2005; 237(3): 803 - 818.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. S. Allen
Mid-Term Results After Thoracoscopic Transmyocardial Laser Revascularization
Ann. Thorac. Surg., August 1, 2005; 80(2): 553 - 558.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. D. Luketich, S. R. Land, E. A. Sullivan, M. Alvelo-Rivera, J. Ward, P. O. Buenaventura, R. J. Landreneau, L. A. Hart, and H. C. Fernando
Thoracic Epidural Versus Intercostal Nerve Catheter Plus Patient-Controlled Analgesia: A Randomized Study
Ann. Thorac. Surg., June 1, 2005; 79(6): 1845 - 1850.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Watanabe, T. Koyanagi, T. Obama, H. Ohsawa, T. Mawatari, N. Takahashi, Y. Ichimiya, and T. Abe
Assessment of node dissection for clinical stage I primary lung cancer by VATS
Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 745 - 752.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. Ohtsuka, H. Nomori, H. Horio, T. Naruke, and K. Suemasu
Is Major Pulmonary Resection by Video-Assisted Thoracic Surgery an Adequate Procedure in Clinical Stage I Lung Cancer?
Chest, May 1, 2004; 125(5): 1742 - 1746.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
L. Solaini, F. Prusciano, P. Bagioni, and D.B. Poddie
Long-term results of video-assisted thoracic surgery lobectomy for stage I non-small cell lung cancer: a single-centre study of 104 cases
Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 57 - 62.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Gharagozloo, B. Tempesta, M. Margolis, and E. P. Alexander
Video-assisted thoracic surgery lobectomy for Stage I lung cancer
Ann. Thorac. Surg., October 1, 2003; 76(4): 1009 - 1015.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Nomori, T. Ohtsuka, H. Horio, T. Naruke, and K. Suemasu
Thoracoscopic Lobectomy for Lung Cancer With a Largely Fused Fissure
Chest, February 1, 2003; 123(2): 619 - 622.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W. R. Smythe
Treatment of Stage I Non-small Cell Lung Carcinoma
Chest, January 1, 2003; 123(1_suppl): 181S - 187S.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. J. Daniels, S. S. Balderson, M. W. Onaitis, and T. A. D'Amico
Thoracoscopic lobectomy: a safe and effective strategy for patients with stage i lung cancer
Ann. Thorac. Surg., September 1, 2002; 74(3): 860 - 864.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. P.C. Yim
VATS major pulmonary resection revisited--controversies, techniques, and results
Ann. Thorac. Surg., August 1, 2002; 74(2): 615 - 623.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W. W. L. Li, T. W. Lee, S. S. Y. Lam, C. S. H. Ng, A. D. L. Sihoe, I. Y. P. Wan, and A. P. C. Yim
Quality of Life Following Lung Cancer Resection* : Video-Assisted Thoracic Surgery vs Thoracotomy
Chest, August 1, 2002; 122(2): 584 - 589.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Nomori, H. Horio, T. Naruke, and K. Suemasu
Posterolateral thoracotomy is behind limited thoracotomy and thoracoscopic surgery in terms of postoperative pulmonary function and walking capacity
Eur. J. Cardiothorac. Surg., January 1, 2002; 21(1): 155 - 156.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Tsuguo Naruke
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nomori, H.
Right arrow Articles by Suemasu, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nomori, H.
Right arrow Articles by Suemasu, K.
Related Collections
Right arrow